Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction)

Abstract:

:Neutrophilic-chronic myeloid leukemia (CML-N) is a rare myeloproliferative disorder that runs a much more benign course than chronic myeloid leukemia, and for which no specific underlying molecular lesion has been described so far. We have analyzed the genomic DNA by Southern blotting and the BCR/ABL hybrid gene transcripts by reverse transcriptase-polymerase chain reaction in three patients with clinical findings of CML-N, who did have a t(9;22) chromosomal translocation. In all patients we have found a rare type of BCR/ABL rearrangement, with a breakpoint between exons c3 and c4 of the BCR gene (corresponding to BCR exons 19 and 20). This was confirmed by hybridization with an oligonucleotide probe spanning the c3/a2 region. This type of junction causes almost the entire BCR gene to fuse with ABL. The junction is in frame and it gives rise to a fusion protein of predicted 230 kD. Our data now provide a molecular diagnostic marker for CML-N, and they are consistent with the notion that the inclusion or exclusion of BCR exons in the fusion protein affects dramatically its capacity to derange myeloid proliferation and differentiation, leading to the appearance of different disease phenotypes.

journal_name

Blood

journal_title

Blood

authors

Pane F,Frigeri F,Sindona M,Luciano L,Ferrara F,Cimino R,Meloni G,Saglio G,Salvatore F,Rotoli B

subject

Has Abstract

pub_date

1996-10-01 00:00:00

pages

2410-4

issue

7

eissn

0006-4971

issn

1528-0020

journal_volume

88

pub_type

杂志文章

相关文献

BLOOD文献大全
  • RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy.

    abstract::Vaccination with antigen-presenting cells (APCs) engineered to mimic mechanisms of immune stimulation represents a promising approach for cancer immunotherapy. Dendritic cell vaccines have entered phase 3 testing in adult malignancies, but such vaccines in children have been limited. We demonstrate that CD40-activated...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2379

    authors: Coughlin CM,Vance BA,Grupp SA,Vonderheide RH

    更新日期:2004-03-15 00:00:00

  • Montreal platelet syndrome: a defect in calcium-activated neutral proteinase (calpain).

    abstract::Platelets from patients with Montreal platelet syndrome (MPS) consistently display a defect in the mechanisms that regulate platelet size during shape change and undergo spontaneous aggregation and stir-induced microaggregate formation. We now provide data that the surface glycoprotein composition of MPS platelets is ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Okita JR,Frojmovic MM,Kristopeit S,Wong T,Kunicki TJ

    更新日期:1989-08-01 00:00:00

  • Somatic mosaicism and compound heterozygosity in female hemophilia B.

    abstract::Sequencing the complete factor IX gene of 2 sisters with hemophilia B with different phenotypes and no family history of hemorrhagic diathesis revealed a common 5' splice site mutation in intron 3 (T6704C) in both and an additional missense mutation (I344T) in one. The presence of dysfunctional antigen in the latter s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Costa JM,Vidaud D,Laurendeau I,Vidaud M,Fressinaud E,Moisan JP,David A,Meyer D,Lavergne JM

    更新日期:2000-08-15 00:00:00

  • Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia.

    abstract::The anti-CD33 antibody calicheamicinconjugate gemtuzumab ozogamicin (GO) was used to treat 16 patients with acute promyelocytic leukemia (APL) who had relapsed at the molecular level. Of these patients, 8 were experiencing a first, 5 a second, 2 a third, and 1 a fourth relapse. GO was administered at 6 mg/m2 for 2 dos...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2004-04-1550

    authors: Lo-Coco F,Cimino G,Breccia M,Noguera NI,Diverio D,Finolezzi E,Pogliani EM,Di Bona E,Micalizzi C,Kropp M,Venditti A,Tafuri A,Mandelli F

    更新日期:2004-10-01 00:00:00

  • Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

    abstract::Transplantation-associated thrombotic microangiopathy (TA-TMA) is a challenging diagnosis after hematopoietic stem cell transplantation. Although endothelial injury represents the final common pathway of disease, the exact pathophysiology of TA-TMA remains unclear. Potential causes include infections, chemotherapy, ra...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2011-02-321315

    authors: Laskin BL,Goebel J,Davies SM,Jodele S

    更新日期:2011-08-11 00:00:00

  • The expanding role(s) of eosinophils in health and disease.

    abstract::Surprisingly, the role(s) of eosinophils in health and disease is often summarized by clinicians and basic research scientists as a pervasive consensus opinion first learned in medical/graduate school. Eosinophils are rare white blood cells whose activities are primarily destructive and are only relevant in parasitic ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2012-06-330845

    authors: Jacobsen EA,Helmers RA,Lee JJ,Lee NA

    更新日期:2012-11-08 00:00:00

  • Modulation of the apoptotic response of human myeloid leukemia cells to a diphtheria toxin granulocyte-macrophage colony-stimulating factor fusion protein.

    abstract::It has previously been shown that human granulocyte-macrophage colony-stimulating factor (GM-CSF) can be fused to a truncated diphtheria toxin (DT) to produce a recombinant fusion toxin that kills GM-CSF receptor-bearing cells. We now report that DT388-GM-CSF induces apoptosis and inhibition of colony formation in sem...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Frankel AE,Hall PD,Burbage C,Vesely J,Willingham M,Bhalla K,Kreitman RJ

    更新日期:1997-11-01 00:00:00

  • L-selectin shedding affects bacterial clearance in the lung: a new regulatory pathway for integrin outside-in signaling.

    abstract::Pneumonia induced by Gram-negative bacteria is a common and serious disease associated with high morbidity and mortality. Elimination of bacterial pathogens relies on the recruitment and functions of neutrophils. The adhesion molecule L-selectin has recently been implicated in integrin activation in neutrophils (insid...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000685

    authors: Cappenberg A,Margraf A,Thomas K,Bardel B,McCreedy DA,Van Marck V,Mellmann A,Lowell CA,Zarbock A

    更新日期:2019-10-24 00:00:00

  • The vascular endothelial-cadherin promoter directs endothelial-specific expression in transgenic mice.

    abstract::Vascular endothelial-cadherin (VE-cadherin) is a calcium-dependent adhesive molecule, exclusively and constitutively expressed in endothelial cells. Analysis of the VE-cadherin promoter fused to a reporter gene in bovine aortic endothelial cells showed three major functional regions. The proximal region alone (-139, +...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gory S,Vernet M,Laurent M,Dejana E,Dalmon J,Huber P

    更新日期:1999-01-01 00:00:00

  • Identification of a gene expression signature associated with pediatric AML prognosis.

    abstract::Most patients with acute myeloid leukemia (AML) enter complete remission (CR) after treatment with chemotherapy, but a large number of them experience relapse with resistant disease. To identify genes that are associated with their prognoses, we analyzed gene expression in 54 pediatric patients with AML using an oligo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-02-0578

    authors: Yagi T,Morimoto A,Eguchi M,Hibi S,Sako M,Ishii E,Mizutani S,Imashuku S,Ohki M,Ichikawa H

    更新日期:2003-09-01 00:00:00

  • TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection.

    abstract::Cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs) are synthetic ODNs with unmethylated DNA sequences that mimic viral and bacterial DNA and protect against infectious agents and tumor challenge. We show that CpG ODNs markedly accelerated graft-versus-host disease (GVHD) lethality by Toll-like receptor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-113670

    authors: Taylor PA,Ehrhardt MJ,Lees CJ,Panoskaltsis-Mortari A,Krieg AM,Sharpe AH,Murphy WJ,Serody JS,Hemmi H,Akira S,Levy RB,Blazar BR

    更新日期:2008-10-15 00:00:00

  • Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.

    abstract::Myelodysplastic syndromes (MDSs) are chronic and often progressive myeloid neoplasms associated with remarkable heterogeneity in the histomorphology and clinical course. Various somatic mutations are involved in the pathogenesis of MDS. Recently, mutations in a gene encoding a spliceosomal protein, SF3B1, were discove...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-12-399774

    authors: Makishima H,Visconte V,Sakaguchi H,Jankowska AM,Abu Kar S,Jerez A,Przychodzen B,Bupathi M,Guinta K,Afable MG,Sekeres MA,Padgett RA,Tiu RV,Maciejewski JP

    更新日期:2012-04-05 00:00:00

  • Factor IXAlabama: a point mutation in a clotting protein results in hemophilia B.

    abstract::Factor IXAlabama is a variant factor IX molecule responsible for a clinically moderate form of hemophilia B. Twenty-five kilobases (kb) of the variant gene, including seven exons coding for the structural protein, were cloned and characterized. The restriction map and the arrangement of coding regions are identical to...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Davis LM,McGraw RA,Ware JL,Roberts HR,Stafford DW

    更新日期:1987-01-01 00:00:00

  • Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia.

    abstract::Chromosomal translocations involving the platelet-derived growth factor beta receptor (PDGFbetaR) gene have been reported in some patients with chronic myelomonocytic leukemia (CMML). The resultant fusion proteins have constitutive PDGFbetaR tyrosine kinase activity, but the partner genes previously reported (tel, Hun...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.8.2518

    authors: Magnusson MK,Meade KE,Brown KE,Arthur DC,Krueger LA,Barrett AJ,Dunbar CE

    更新日期:2001-10-15 00:00:00

  • Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience.

    abstract::In multiple myeloma, cytogenetic changes are important predictors of patient outcome. In this setting, the most important changes are deletion 17p, del(17p), and translocation of chromosomes 4 and 14, t(4;14), conferring a poor outcome. However, a certain degree of heterogeneity is observed in the survival of these hi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-587964

    authors: Hebraud B,Magrangeas F,Cleynen A,Lauwers-Cances V,Chretien ML,Hulin C,Leleu X,Yon E,Marit G,Karlin L,Roussel M,Stoppa AM,Belhadj K,Voillat L,Garderet L,Macro M,Caillot D,Mohty M,Facon T,Moreau P,Attal M,Munshi N

    更新日期:2015-03-26 00:00:00

  • Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma.

    abstract::Understanding the molecular pathogenesis of lymphoma has led to paradigm-changing treatment opportunities. One example involves tailoring specific agents based on the cell of origin in aggressive lymphomas. Germinal center (GC)-derived diffuse large B-cell lymphoma (DLBCL) is known to be driven by an addiction to Bcl6...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-02-485441

    authors: Amengual JE,Clark-Garvey S,Kalac M,Scotto L,Marchi E,Neylon E,Johannet P,Wei Y,Zain J,O'Connor OA

    更新日期:2013-09-19 00:00:00

  • Evidence that the Pim1 kinase gene is a direct target of HOXA9.

    abstract::The HOXA9 homeoprotein exerts dramatic effects in hematopoiesis. Enforced expression of HOXA9 enhances proliferation of primitive blood cells, expands hematopoietic stem cells (HSCs), and leads to myeloid leukemia. Conversely, loss of HOXA9 inhibits proliferation and impairs HSC function. The pathways by which HOXA9 a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-08-043356

    authors: Hu YL,Passegué E,Fong S,Largman C,Lawrence HJ

    更新日期:2007-06-01 00:00:00

  • Platelet adhesion involves a novel interaction between vimentin and von Willebrand factor under high shear stress.

    abstract::The interaction between platelet receptor glycoprotein Ibα and the A1 domain of von Willebrand factor (VWF) mediates tethering/translocation of platelets to sites of vascular injury. Unexpectedly, we observed platelets translocating over A1A2A3 domains protein slower than on A1 domain at high shear stress. This observ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-10-530428

    authors: Da Q,Behymer M,Correa JI,Vijayan KV,Cruz MA

    更新日期:2014-04-24 00:00:00

  • Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518.

    abstract::FLT3 is constitutively activated by internal tandem duplications (ITDs) in the juxtamembrane domain or by activation loop mutations in acute myeloid leukemia (AML). We tested the sensitivity of 8 activation loop mutations to the small molecule FLT3 inhibitor, MLN518. Each FLT3 activation loop mutant, including D835Y, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4446

    authors: Clark JJ,Cools J,Curley DP,Yu JC,Lokker NA,Giese NA,Gilliland DG

    更新日期:2004-11-01 00:00:00

  • Dual effects of macrophage inflammatory protein-1alpha on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease.

    abstract::Recent data have implicated macrophage inflammatory protein-1alpha (MIP-1alpha) in multiple myeloma (MM)-associated osteolysis. However, it is unclear whether the chemokine's effects are direct, to enhance osteolysis, or indirect and mediated through a reduction in tumor burden, or both. It is also unclear whether MIP...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-12-3905

    authors: Oyajobi BO,Franchin G,Williams PJ,Pulkrabek D,Gupta A,Munoz S,Grubbs B,Zhao M,Chen D,Sherry B,Mundy GR

    更新日期:2003-07-01 00:00:00

  • Eosinophil-specific deletion of IκBα in mice reveals a critical role of NF-κB-induced Bcl-xL for inhibition of apoptosis.

    abstract::Eosinophils are associated with type 2 immune responses to allergens and helminths. They release various proinflammatory mediators and toxic proteins on activation and are therefore considered proinflammatory effector cells. Eosinophilia is promoted by the cytokines interleukin (IL)-3, IL-5, and granulocyte macrophage...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-10-607788

    authors: Schwartz C,Willebrand R,Huber S,Rupec RA,Wu D,Locksley R,Voehringer D

    更新日期:2015-06-18 00:00:00

  • Lymphokine(s) from isolated T lymphocyte subpopulations support multilineage hematopoietic colony and megakaryocytic colony formation.

    abstract::Conditioned medium derived from peripheral mononuclear low-density cells stimulated with phytohemagglutinin (PHA) supports the growth of noncommitted hematopoietic progenitors from marrow and peripheral blood cells. These immature progenitors (CFU-GEMM) can be identified in culture as multilineage hematopoietic coloni...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kanz L,Löhr GW,Fauser AA

    更新日期:1986-11-01 00:00:00

  • Crosstalk between RANKL and Fas signaling in dendritic cells controls immune tolerance.

    abstract::Although receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) signaling has been shown to prolong the survival of mature dendritic cells (DCs), the association of RANKL pathway with Fas-mediated apoptosis is obscure. Here, we found that bone marrow-derived DCs (BMDCs) from the Fas-deficient strain MRL/lpr m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-11-059980

    authors: Izawa T,Ishimaru N,Moriyama K,Kohashi M,Arakaki R,Hayashi Y

    更新日期:2007-07-01 00:00:00

  • Loss of DGKε induces endothelial cell activation and death independently of complement activation.

    abstract::Atypical hemolytic uremic syndrome (aHUS) is classically described to result from a dysregulation of the complement alternative pathway, leading to glomerular endothelial cell (EC) damage and thrombosis. However, recent findings in families with aHUS of mutations in the DGKE gene, which is not an integral component of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-06-579953

    authors: Bruneau S,Néel M,Roumenina LT,Frimat M,Laurent L,Frémeaux-Bacchi V,Fakhouri F

    更新日期:2015-02-05 00:00:00

  • A naturally occurring E30Q mutation in the Gla domain of protein Z causes its impaired secretion and subsequent deficiency.

    abstract::Protein Z is a vitamin K-dependent glycoprotein that plays a role in the regulation of coagulation. A nucleotide substitution of G by C in exon II of the protein Z gene, resulting in the replacement of Glu-30 with Gln (E30Q), and a G to A transition at the 79th nucleotide in intron F (IntF79G/A) were heterozygously id...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-06-2250

    authors: Souri M,Koseki-Kuno S,Iwata H,Kemkes-Matthes B,Ichinose A

    更新日期:2005-04-15 00:00:00

  • Induction of an embryonic globin gene promoter by short-chain fatty acids.

    abstract::Short-chain fatty acids (SCFAs) and dimethyl sulfoxide (DMSO) induce adult erythroid differentiation in murine erythroleukemia (MEL) cells, but only SCFAs concurrently up-regulate expression from the endogenous embryonic globin gene epsilony. The epsilony promoter, linked to a reporter gene and stably transfected into...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-12-3766

    authors: Dempsey NJ,Ojalvo LS,Wu DW,Little JA

    更新日期:2003-12-01 00:00:00

  • HbF reactivation in sibling BFU-E colonies: synergistic interaction of kit ligand with low-dose dexamethasone.

    abstract::Mechanisms underlying fetal hemoglobin (HbF) reactivation in stress erythropoiesis have not been fully elucidated. We suggested that a key role is played by kit ligand (KL). Because glucocorticoids (GCs) mediate stress erythropoiesis, we explored their capacity to potentiate the stimulatory effect of KL on HbF reactiv...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-05-1477

    authors: Gabbianelli M,Testa U,Massa A,Morsilli O,Saulle E,Sposi NM,Petrucci E,Mariani G,Peschle C

    更新日期:2003-04-01 00:00:00

  • Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii.

    abstract::The activation of murine dendritic cells by Toxoplasma gondii has recently been shown to depend on a parasite protein that signals through the chemokine receptor CCR5. Here we demonstrate that this molecule, cyclophilin-18 (C-18), is an inhibitor of HIV-1 cell fusion and infection with cell-free virus. T gondii C-18 e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-04-1096

    authors: Golding H,Aliberti J,King LR,Manischewitz J,Andersen J,Valenzuela J,Landau NR,Sher A

    更新日期:2003-11-01 00:00:00

  • Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.

    abstract::The effects of selectively depleting CD8+ cells from donor bone marrow were assessed in 36 patients receiving transplantation from an HLA-identical sibling as treatment for leukemia. Donor bone marrow underwent ex vivo treatment using anti-Leu-2 monoclonal antibody and complement. Patients received cyclosporine post-t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Champlin R,Ho W,Gajewski J,Feig S,Burnison M,Holley G,Greenberg P,Lee K,Schmid I,Giorgi J

    更新日期:1990-07-15 00:00:00

  • Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia.

    abstract::The risk of development of CNS leukemia was investigated in 153 adults with acute lymphocytic leukemia (ALL) who received systemic combination chemotherapy without CNS prophylaxis. Overall, 31 patients (20%) developed CNS leukemia after a median of 6 months of therapy; the estimated 1-year incidence of CNS leukemia wa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kantarjian HM,Walters RS,Smith TL,Keating MJ,Barlogie B,McCredie KB,Freireich EJ

    更新日期:1988-11-01 00:00:00